|[January 03, 2014]
Research and Markets: 2013 Report on the International Vaccine Market - Global Forecasts To 2022
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/xkfs22/vaccine_market_by)
has announced the addition of the "2013
Report on the International Vaccine Market - Global Forecasts To 2022"
report to their offering.
In general, the vaccine technology market is largely perceived
negatively as a low-profit venture owing to the domination of top five
companies, namely, Sanofi (France), Glaxo Smithkline (U.K.), Merck
(U.S.), Pfizer (U.S.), and Novartis (Switzerland). Furthermore, a strong
patent portfolio and the need for large investments towards vaccine
development have limited the scope of entry for new companies.
This report analyzes the vaccine technology market both in terms of
qualitative (technological) and quantitative (revenue) perspectives. The
technological analysis includes a discussion on different classes of
vaccines, vaccine adjuvants, and commercially available producs. The
market revenue analysis includes market segmentation and the expected
market position by 2022, with the projected growth rate.
The vaccine market is classified by technology class, types, end users,
disease indication, and geography. The details on the emerging
approaches to vaccine development such as reverse vaccinology,
personalized vaccinomics, and systems vaccinomics are discussed.
Furthermore, key research centers, with their critical areas of research
in the vaccine space, have been provided. An overview of regulations
across various geographical regions has been covered. The complete value
chain of the vaccine market is schematically represented and the
significance of each stakeholder has been briefed.
As well as technological and market analysis, the investor climate has
been assessed by tracking the complete investor network and collecting
data on funds/grants and investments made towards vaccine development.
Key Topics Covered:
2 Executive Summary
3 Technology Snapshot (Page No. - 31)
4 Vaccine Research Portfolio
5 Value Chain Analysis
6 Market Landscape
7 Technology Adoption
8 Investment Analysis
9 Competitive Landscape
10 Regulatory Landscape
11 Patent Analysis
12 Analyst Recommendations
13 Company Profiles
Antigen Express, INC
Biondvax Pharmaceuticals LTD
Glaxo Smithkline PLC
Immune Targeting Systems (ITS)
Merck & CO, INC
For more information visit http://www.researchandmarkets.com/research/xkfs22/vaccine_market_by
[ Back To TMCnet.com's Homepage ]